Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerome Teitel

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand DiseaseMichelle Sholzberg, Kate Khair, Hassan Yaish, et al.
Research and Practice in Thrombosis and Haemostasis|April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective studyDavide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 2, 2011
Recombinant factor VIIa affects anastomotic patency of vascular grafts in a rabbit modelC David Mazer, Howard Leong-Poi, Tejinder Chhina, et al.
Journal of Blood Medicine|September 16, 2025
Journeying Towards Excellence in the Care of Patients with Haemophilia and Other Inherited Bleeding Disorders From a Developing World: Insights From TanzaniaStella Samson Rwezaula, Samson D Mtoba, Rashid A Gosse, et al.
Diabetes Care|August 28, 2002
Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetesDavid J A Jenkins, Cyril W C Kendall, Livia S A Augustin, et al.
The New England Journal of Medicine|September 25, 2024
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia BAdam Cuker, Kaan Kavakli, Laurent Frenzel, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
TH Open : Companion Journal to Thrombosis and Haemostasis|July 8, 2021
Real-World Data on the Effectiveness and Safety of wilate for the Treatment of von Willebrand DiseaseMichelle Sholzberg, Kate Khair, Hassan Yaish, et al.
Research and Practice in Thrombosis and Haemostasis|April 7, 2022
Switching to nonacog beta pegol in hemophilia B: Outcomes from a Canadian real-world, multicenter, retrospective studyDavide Matino, Alfonso Iorio, Arun Keepanasseril, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 2, 2011
Recombinant factor VIIa affects anastomotic patency of vascular grafts in a rabbit modelC David Mazer, Howard Leong-Poi, Tejinder Chhina, et al.
Journal of Blood Medicine|September 16, 2025
Journeying Towards Excellence in the Care of Patients with Haemophilia and Other Inherited Bleeding Disorders From a Developing World: Insights From TanzaniaStella Samson Rwezaula, Samson D Mtoba, Rashid A Gosse, et al.
Diabetes Care|August 28, 2002
Effect of wheat bran on glycemic control and risk factors for cardiovascular disease in type 2 diabetesDavid J A Jenkins, Cyril W C Kendall, Livia S A Augustin, et al.
The New England Journal of Medicine|September 25, 2024
Gene Therapy with Fidanacogene Elaparvovec in Adults with Hemophilia BAdam Cuker, Kaan Kavakli, Laurent Frenzel, et al.
The New England Journal of Medicine|December 7, 2017
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX VariantLindsey A George, Spencer K Sullivan, Adam Giermasz, et al.
Pageof 4